Next Article in Journal
Pollen-Food Allergy Syndrome: A not so Rare Disease in Childhood
Next Article in Special Issue
Conventional and Complementary Medicine Health Care Practitioners’ Perspectives on Interprofessional Communication: A Qualitative Rapid Review
Previous Article in Journal
Structural, Dermal and Ungual Characteristics of the Foot in Patients with Type II Diabetes
Previous Article in Special Issue
Health Behavior Change and Complementary Medicine Use: National Health Interview Survey 2012
Open AccessCase Report

Antrodia Cinnamomea Prolongs Survival in a Patient with Small Cell Lung Cancer

by Huei Long 1, Chi-Tan Hu 2,3 and Ching-Feng Weng 4,5,6,*
Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Hualien 97401, Taiwan
Research Centre for Hepatology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97002, Taiwan
School of Medicine, Tzu Chi University, Hualien 97002, Taiwan
Department of Basic Medical Science, Center for Transitional Medicine, Xiamen Medical College, Xiamen 361023, China
Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
Department of Food Science, National Kinmen University, Kinmen 89250, Taiwan
Author to whom correspondence should be addressed.
Medicina 2019, 55(10), 640;
Received: 18 July 2019 / Revised: 11 September 2019 / Accepted: 20 September 2019 / Published: 26 September 2019
(This article belongs to the Special Issue Complementary and Integrative Medicine)
Introduction: Antrodia cinnamomea (AC) is an extremely rare medicinal fungus native to forested regions of Taiwan. It possesses numerous biological activities, especially anti-tumor effects shown in various in vitro cancer cells and in vivo animal models. However, there are few clinical reports about AC as a treatment for cancer patients. This report attempts to demonstrate the therapeutic effect of dish-cultured AC (DAC) on a small cell lung cancer (SCLC) patient taken orally for an extended duration. Patient concerns: An 88-year-old male with a history of diabetes mellitus and hypertension visited the outpatient department with the symptoms of dyspnea and a cough for two weeks. After a diagnosis of SCLC, the patient declined both chemotherapy and radiotherapy because of the side effects and only accepted supportive care without additional therapy. Diagnosis: Limited-stage SCLC (T4N2M1a, stage IV) after the chest radiograph, computed tomography-guided biopsy, and pathological diagnosis. Interventions: The patient was prescribed DAC with an increasing dosage, from 5 g/d up to 10 g/d DAC, for six months, without radiation or chemotherapy treatment. Outcomes: DAC caused the tumor to shrink substantially. Surprisingly, the patient survived for 32 months without relapse after six months of DAC treatment. Laboratory examinations indicated that the patient’s health had improved significantly, reverting to near normal levels. Notably, he had a good quality of life with a high Barthel index score. Unfortunately, this patient died of septic shock caused by acute cholangitis. Conclusion: DAC may exert an anti-cancer effect, which can lead to tumor regression. This is supposed to be achieved by the combined DAC’s immunomodulatory, anti-angiogenic, anti-metastatic, anti-proliferative, and pro-apoptotic effects mediated through multiple signaling pathways. We propose that DAC can be used as a complementary medicine to prolong the life expectancy and improve the life quality of SCLC patients. View Full-Text
Keywords: Antrodia cinnamomea; small cell lung cancer; complementary medicine; prolong survival Antrodia cinnamomea; small cell lung cancer; complementary medicine; prolong survival
Show Figures

Figure 1

MDPI and ACS Style

Long, H.; Hu, C.-T.; Weng, C.-F. Antrodia Cinnamomea Prolongs Survival in a Patient with Small Cell Lung Cancer. Medicina 2019, 55, 640.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop